The Role of Oxidative Stress and the Effects of Antioxidants on the Incidence of Infectious Complications of Chronic Lymphocytic Leukemia

Table 3

Antileukemic therapy and comorbidities.

Antileukemic therapy	Patients with CLL treated with antileukemic therapy (group A); Number of patients: 44	Patients with CLL treated with antileukemic therapy and antioxidants (group B); Number of patients: 40
Chl + PDN	10	10	NS
CVP	10	9	NS
Fludarabine	5	5	NS
RFC	4	4	NS
Alemtuzumab	2	2	NS
Vitamin C	—	40	NA
Smokers	19	16	NS
Comorbidities
Arterial hypertension	3	3	NS
Respiratory diseases	5	2	<0.05
Diabetes mellitus	3	1	NS
Liver disease	2	0	NS
Kidney failure	1	0	NS
Dyslipidemic sdr.	0	2	NS
Secondary cancer	4	2	<0.05